Magnus Financial Group’s Immunome IMNM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $498K | Hold |
53,536
| – | – | 0.04% | 234 |
|
2025
Q1 | $360K | Hold |
53,536
| – | – | 0.03% | 263 |
|
2024
Q4 | $569K | Buy |
53,536
+27,777
| +108% | +$295K | 0.05% | 200 |
|
2024
Q3 | $377K | Hold |
25,759
| – | – | 0.04% | 240 |
|
2024
Q2 | $312K | Hold |
25,759
| – | – | 0.04% | 249 |
|
2024
Q1 | $636K | Hold |
25,759
| – | – | 0.08% | 165 |
|
2023
Q4 | $276K | Hold |
25,759
| – | – | 0.04% | 231 |
|
2023
Q3 | $215K | Hold |
25,759
| – | – | 0.03% | 243 |
|
2023
Q2 | $204K | Hold |
25,759
| – | – | 0.03% | 257 |
|
2023
Q1 | $129K | Hold |
25,759
| – | – | 0.02% | 264 |
|
2022
Q4 | $56.9K | Hold |
25,759
| – | – | 0.01% | 259 |
|
2022
Q3 | $114K | Hold |
25,759
| – | – | 0.02% | 243 |
|
2022
Q2 | $83K | Hold |
25,759
| – | – | 0.02% | 268 |
|
2022
Q1 | $146K | Hold |
25,759
| – | – | 0.02% | 279 |
|
2021
Q4 | $334K | Hold |
25,759
| – | – | 0.06% | 180 |
|
2021
Q3 | $627K | Hold |
25,759
| – | – | 0.13% | 108 |
|
2021
Q2 | $446K | Buy |
25,759
+11,111
| +76% | +$192K | 0.1% | 140 |
|
2021
Q1 | $496K | Buy |
+14,648
| New | +$496K | 0.12% | 112 |
|